2012
DOI: 10.1016/j.jns.2012.03.017
|View full text |Cite
|
Sign up to set email alerts
|

Increasing age at disability milestones among MS patients in the MSBase Registry

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
25
2
1

Year Published

2013
2013
2021
2021

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 35 publications
(31 citation statements)
references
References 26 publications
(34 reference statements)
2
25
2
1
Order By: Relevance
“…The limitations relate to the biases attendant to observational studies,24 including selection bias, confounding by unmeasured variables (ie, lesion burden on MRI at baseline) and lack of data completeness for some variables. Demographic and disability data were available for all patients, while ‘reasons for DMT discontinuation’ is currently not a required field in the MSBase minimum data set and was not recorded for most of the stoppers.…”
Section: Discussionmentioning
confidence: 99%
“…The limitations relate to the biases attendant to observational studies,24 including selection bias, confounding by unmeasured variables (ie, lesion burden on MRI at baseline) and lack of data completeness for some variables. Demographic and disability data were available for all patients, while ‘reasons for DMT discontinuation’ is currently not a required field in the MSBase minimum data set and was not recorded for most of the stoppers.…”
Section: Discussionmentioning
confidence: 99%
“…This concurs with results from a self-enrolling online registry—NARCOMS—that reported one-third of their participants enrolled within two years of diagnosis and also had a median disability score of 3 (1–5) on the PDDS [22]. Compared to the MSBase international registry (which is physician enrolled) with over 11,000 participants from 26 countries, in general the participants in our study were older at enrolment, were diagnosed at an older age, and had a shorter disease duration at enrolment [45] (Table 9). It is possible that patients who are recently diagnosed seek out information and support through online communities early in the illness and may be more motivated to contribute to research in the hope that it will offer some new evidence for the successful treatment of their condition.…”
Section: Discussionmentioning
confidence: 99%
“…Although the small sample size may have limited our ability to detect a significant effect of EPVS toward accrual of disability and brain damage, the provided estimates and confidence intervals (Tables and ) represent a useful resource to plan future prospective studies of larger cohorts. In the present study, we investigated the effect of EPVS on disease worsening using selection and group allocation criteria based on an established disability milestone (EDSS≥3) employed in other studies . Different inclusion and group definition criteria may improve our sensitivity in detecting differences in EPVS, for instance, between faster and slower progressive patients, in future studies.…”
Section: Discussionmentioning
confidence: 99%